RhumbLine Advisers’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,733
| Closed | -$93K | – | 3301 |
|
|
2022
Q1 | $93K | Buy |
7,733
+172
| +2% | +$2.07K | ﹤0.01% | 2899 |
|
|
2021
Q4 | $148K | Sell |
7,561
-163
| -2% | -$3.19K | ﹤0.01% | 2887 |
|
|
2021
Q3 | $201K | Buy |
7,724
+500
| +7% | +$13K | ﹤0.01% | 2915 |
|
|
2021
Q2 | $159K | Buy |
+7,224
| New | +$159K | ﹤0.01% | 2940 |
|
|
2019
Q2 | – | Sell |
-1,149
| Closed | -$44K | – | 3022 |
|
|
2019
Q1 | $44K | Sell |
1,149
-20
| -2% | -$766 | ﹤0.01% | 2925 |
|
|
2018
Q4 | $54K | Buy |
1,169
+375
| +47% | +$17.3K | ﹤0.01% | 2938 |
|
|
2018
Q3 | $108K | Sell |
794
-49
| -6% | -$6.67K | ﹤0.01% | 2856 |
|
|
2018
Q2 | $398K | Buy |
+843
| New | +$398K | ﹤0.01% | 2406 |
|